Clinical Outcomes and Quality of Life in Recipients of Livers Donated after Cardiac Death
Table 2
Baseline characteristics of liver transplant recipients with a quality of life assessment.
DCD ()
DBD ()
Age at survey
54.1 ± 14.1
51.7 ± 13.4
Gender (% male)
67.6%
65.4%
Calculated MELD at liver transplantation
22.4 ± 10.2
20.7 ± 10.7
MELD upgrade at liver transplantation (%)
38.6%
34.2%
Etiology of liver disease
HCV
30.3%
32.1%
EtOH
16%
12.7%
HCV/EtOH
6.9%
9.9%
NASH/cryptogenic
12.8%
15.8%
Fulminant
4.2%
3.1%
HCC at liver transplantation
29.3%
26.4%
Liver-kidney transplant
3%
17.9%
Cold ischemia time (hrs)
5.8 ± 1.4
5.3 ± 1.7
Warm ischemia time (min)
15.1 ± 5.8
Time since liver transplantation (days)
654 ± 219
1014 ± 608
Ischemic cholangiopathy
26.6%
0%
DCD: donation after cardiac death, DBD: donation after brain death, MELD: model of end stage liver disease, LT: liver transplantation, HCV: hepatitis C virus, EtOH: ethanol, NASH: nonalcoholic steatohepatitis, and HCC: hepatocellular carcinoma.
